B of A Securities Maintains Buy on AbbVie, Raises Price Target to $276

Benzinga Newsdesk www.benzinga.com Positive 78.3%

Neg 0% Neu 0% Pos 78.3%

B of A Securities analyst Geoff Meacham maintains AbbVie (NYSE:ABBV) with a Buy and raises the price target from $234 to $276.